# Everything you need to know about Sunrest Lifescience Limited Rights Issue August 2026

**URL:** https://tradingqna.com/t/everything-you-need-to-know-about-sunrest-lifescience-limited-rights-issue-august-2026/197149
**Category:** Rights issue
**Created:** [August 18, 2026, 3:18am UTC](https://tradingqna.com/t/everything-you-need-to-know-about-sunrest-lifescience-limited-rights-issue-august-2026/197149 "2026-08-18T03:18:27Z")
**Posts on this page:** 1
**Page:** 1

<div class="post-metadata">

### Author: ![Shruthi](https://tradingqna.com/user_avatar/tradingqna.com/shruthi/32/45458_2.png) [@Shruthi](https://tradingqna.com/u/Shruthi)
#### Post date: [August 18, 2026, 3:18am UTC](https://tradingqna.com/t/everything-you-need-to-know-about-sunrest-lifescience-limited-rights-issue-august-2026/197149/1 "2026-08-18T03:18:27Z")

</div>

Sunrest Lifescience has announced a rights issue of 42,91,200 equity shares aggregating up to ₹15.02 crores. The rights issue opens for subscription on August 18, 2026, and closes on August 31, 2026.

Anyone who holds shares of Sunrest Lifescience as of August 10, 2026 (record date) will be eligible to receive Rights Entitlements (REs). These REs will be temporarily traded on the stock exchanges and will then be extinguished. You can either use the REs to apply for the rights shares of the company, or you can sell them in the market.

You can check the announcement from the company [here](https://sunrestlifescience.com/wp-content/uploads/2026/08/Letter-of-Offer-1.pdf).

You will be eligible to receive Rights Entitlements (REs) if you’ve bought the shares on or before August 7, 2026. The ex-date is August 10, 2026.

## Rights issue details

| Issue Period | August 18, 2026 – September 11, 2026 |
| --- | --- |
| RE Trading Period | August 18, 2026 – August 28, 2026 |
| RE Symbol | SUN-RE |
| Issue Price | Rs. 35 per share |
| Ratio | 1:1 |
| EX-date | August 10, 2026 |
| Record Date | August 10, 2026 |
| Tentative Date of Allotment for Rights Shares | |
| Tentative Date of Credit of Rights Shares | |
| Tentative Date of Listing for Rights Shares | |

## How to apply for Sunrest Lifescience Limited Rights Issue?

Once you either receive the REs from the company or purchase them from the market, you can apply for the rights shares using the below methods;

- Online via Netbanking ASBA
- Offline by submitting the [Application Form](https://sunrestlifescience.com/wp-content/uploads/2026/08/Application-Form.pdf)to the nearest branch of [SCSB (Self-Certified Syndicate Bank)  
 ](https://www.sebi.gov.in/sebiweb/other/OtherAction.do?doRecognisedFpi=yes&intmId=34)

**You can check the application process [here](https://tradingqna.com/t/how-do-i-apply-for-the-rights-issue-of-piramal-enterprises/33380/3).**

You will need to enter your Demat account’s [Beneficiary Owner ID](https://support.zerodha.com/category/your-zerodha-account/dp-id-and-bank-details/dp-id-bo-id/articles/dp-name-dp-id-bo-id-and-demat-id)which is a 16-digit number while applying for the rights issue.

The full issue price of **₹35 per share** is payable at the time of application.

**What will happen to my purchased holding of RE shares if I do not apply for the rights issue?**  
Your REs will lapse and you will lose the premium paid to acquire them. The RE will be in the form of temporary demat securities which will lapse if not renounced/exercised once the trading window is closed.

**I don’t have the shares but bought REs, am I still eligible to apply for the rights issue?**  
In case you have bought REs but don’t have shares, you’re still eligible for the rights issue. You may apply for the rights shares either through the RTA’s portal or via net banking ASBA if your bank allows it. If you don’t take any action, and let the REs remain in your Zerodha account, they will lapse after the issue.

You can read more FAQs on Rights Issue and Rights Entitlements [here](https://support.zerodha.com/category/trading-and-markets/corporate-actions/articles/rightsentitlement).

_ **Update** _ - [Extention of Right Issue Closure Date](https://nsearchives.nseindia.com/corporate/SUNRESTLIFESCIENCE_02092026170312_BM_Outcome.pdf)